[1]
“Interleukin-6 as a Risk and Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis”, J. Can. Res. Updates, vol. 13, pp. 42–51, Nov. 2024, doi: 10.30683/1929-2279.2024.13.07.